(Q34843715)

4 August 2017

title

Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro (English)

1 reference

4 August 2017

0 references

6

1 reference

4 August 2017

Frieda Bostick-Bruton

5

object named as

Bostick-Bruton F

1 reference

4 August 2017

Dabholkar M

1

1 reference

4 August 2017

Bradshaw L

2

1 reference

4 August 2017

Parker RJ

3

1 reference

4 August 2017

Gill I

4

1 reference

4 August 2017

Reed E

7

1 reference

4 August 2017

language of work or name

1 reference

1 November 1992

1 reference

Environmental Health Perspectives

4 August 2017

published in

1 reference

4 August 2017

volume

98

1 reference

4 August 2017

page(s)

53-59

1 reference

Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1519597

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1519597

Host-cell reactivation of cisplatin-damaged pRSVcat in a human lymphoid cell line

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1519597

Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1519597

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1519597

Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1519597

Peripheral Blood Leukocytes as a Surrogate Marker for Cisplatin Drug Resistance: Studies of Adduct Levels and the Repair Gene ERCC1

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1519597

The measurement of cisplatin-DNA adduct levels in testicular cancer patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1519597

26 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/1486863

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1486863

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1486863

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1289/EHP.929853

1 reference

4 August 2017

1 reference

4 August 2017

1 reference